MAPT and Alzheimer disease: Immunofluorescent intensity quantification of phospho-Tau (S404) in hippocampus was significantly increased in ADNS as compared to WT (4104.15) and decreased after fasudil treatment (3109.68) (p < 0.01), suggesting a protective effect of fasudil by decreasing Tau formation in AD (Fig. 2B).